Future phases or additional awards of the LymeX Diagnostics Prize are subject to change at the discretion of the competition administrator, and availability and approval of funds.
Prizes
The LymeX Diagnostics Prize is made possible thanks to a more than $10 million pledge from the Steven & Alexandra Cohen Foundation.
In Phase 3 six teams planned clinical performance studies and engaged with the FDA on their plans. In Phase 4 up to seven teams will perform clinical performance studies and file their regulatory submissions to the FDA.
TOTAL AWARDED PRIZES
$5.1 million
Phases 1, 2, and 3
completed
Phase 1 awarded $1 million, 10 teams received $100,000 each.
Phase 2 awarded $2 million; nine teams received $75,000 interim prizes, and five Phase 2 winners received $265,000 each.
Phase 3 awarded $2.1 million, five teams received $420,000 each.
Phase 2 awarded $2 million; nine teams received $75,000 interim prizes, and five Phase 2 winners received $265,000 each.
Phase 3 awarded $2.1 million, five teams received $420,000 each.
Phase 4
planned
Up to seven teams will receive a share of the total Phase 4 prize pool of up to $3 million.